TCMBANKIN003305 |
3beta,20(R),5-alkenyl-stigmastol |
|
|
414.79 |
|
TCMBANKIN005818 |
Thujopsadiene |
thujopsadiene; AC1O575L; 2,4a,8,8-tetramethyl-1,1a,4,5-tetrahydrocyclopropa[j]naphthalene; HIRCZOSUMSSTDU-UHFFFAOYSA-N |
C15H22 |
202.33 g/mol |
CC1=CCC2(CC=CC(C23C1C3)(C)C)C |
TCMBANKIN018561 |
Wighteone |
AIDS071696; AIDS-071696; 5,7-dihydroxy-3-(4-hydroxyphenyl)-6-(3-methylbut-2-enyl)chromen-4-one; wighteone; 5,7-dihydroxy-3-(4-hydroxyphenyl)-6-(3-methylbut-2-enyl)-4-chromenone; C10542; 4H-1-Benzopyran-4-one, 5,7-dihydroxy-3-(4-hydroxyphenyl)-6-(3-methyl-2-butenyl)-; 51225-30-0; 5,7-dihydroxy-3-(4-hydroxyphenyl)-6-(3-methylbut-2-enyl)chromone |
C20H18O5 |
338.35 |
CC(=CCC1=C(C2=C(C=C1O)OC=C(C2=O)C3=CC=C(C=C3)O)O)C |
TCMBANKIN022149 |
Chamissonin diacetate |
[(3aR,4R,5E,7R,9E,11aS)-7-acetoxy-6,10-dimethyl-3-methylene-2-oxo-3a,4,7,8,11,11a-hexahydrocyclodeca[b]furan-4-yl] acetate; [(3aR,4R,5E,7R,9E,11aS)-7-acetyloxy-6,10-dimethyl-3-methylidene-2-oxo-3a,4,7,8,11,11a-hexahydrocyclodeca[b]furan-4-yl] acetate; C09356; acetic acid [(3aR,4R,5E,7R,9E,11aS)-7-acetoxy-2-keto-6,10-dimethyl-3-methylene-3a,4,7,8,11,11a-hexahydrocyclodeca[d]furan-4-yl] ester; 24112-95-6; acetic acid [(3aR,4R,5E,7R,9E,11aS)-7-acetoxy-6,10-dimethyl-3-methylene-2-oxo-3a,4,7,8,11,11a-hexahydrocyclodeca[b]furan-4-yl] ester; chamissonin diacetate; [(3aR,4R,5E,7R,9E,11aS)-7-acetyloxy-6,10-dimethyl-3-methylidene-2-oxo-3a,4,7,8,11,11a-hexahydrocyclodeca[b]furan-4-yl] ethanoate |
C19H24O6 |
348.39 |
CC1=CCC(C(=CC(C2C(C1)OC(=O)C2=C)OC(=O)C)C)OC(=O)C |
TCMBANKIN022954 |
cupreine |
|
C19H22N2O2 |
310.4 g/mol |
C=CC1CN2CCC1CC2C(C3=C4C=C(C=CC4=NC=C3)O)O |
TCMBANKIN024165 |
welensalifactor f1 |
|
C54H80N2O6S2 |
|
CC12CCC3C(C1CCC2C4=COC=C4)CCC5C3(C(CC(C5)SCCCN)OC(=O)C(=O)OC6CC(CC7C6(C8CCC9(C(C8CC7)CCC9C1=COC=C1)C)C)SCCCN)C |
TCMBANKIN024177 |
mayurone |
|
C14H20O |
204.31 g/mol |
CC1(CCCC2(C13CC3C(=O)C=C2)C)C |
TCMBANKIN030527 |
curcumenether |
(+)-Curcumene ether |
C15H22O |
218.33 g/mol |
CC1=CC=C(C=C1)C2(CCCC(O2)(C)C)C |
TCMBANKIN036828 |
Wedelolactone |
NCGC00163667-01; N2131; UNII-0K6L725GNS; 1,8,9-Trihydroxy-3-methoxycoumestan; Ambotz524-12-9; CTK8G3781; 0K6L725GNS; Wedelolactone, European Pharmacopoeia (EP) Reference Standard; SC-67595; ZINC6483512; IKK Inhibitor II, Wedelolactone; GTPL5551; CCG-208289; NCGC00163667-02; SR-05000002318-2; Wedelolactone, >=98% (HPLC), powder; 7-Methoxy-5,11,12-trihydroxy-coumestan; AKOS015897173; AN-45548; C10541; AC1NQZ4Z; CHEMBL97453; BRD-K53635676-001-02-3; 1,8,9-Trihydroxy-3-methoxy-benzo[4,5]furo[3,2-c]chromen-6-one; 7-Methoxy-5,11,12-trihydroxycoumestan; CHEBI:10037; DTXSID60200408; 1,8,9-trihydroxy-3-methoxy-6-benzofurano[3,2-c]chromenone; W4016_SIGMA; Wedelolactone, <i>Eclipta alba; FT-0698529; SCHEMBL601220; MFCD07778564; SR-05000002318; CM-842; 5,11,12-Trihydroxy-7-methoxycoumestan; K00058; 1,8,9-Trihydroxy-3-methoxy-6H-benzofuro[3,2-c][1]benzopyran-6-one; NCGC00163667-03; Wedelolactone, Eclipta alba; BRD-K53635676-001-01-5; 7-methoxy-5,11,12-trihydroxy-coumestan; Wedelolactone; 524W129; SMP2_000112; 1,8,9-trihydroxy-3-methoxy-benzofurano[3,2-c]chromen-6-one; 1,8,9-trihydroxy-3-methoxy-[1]benzofuro[3,2-c]chromen-6-one; 524-12-9; MolPort-003-960-187; 6H-Benzofuro(3,2-c)(1)benzopyran-6-one, 1,8,9-trihydroxy-3-methoxy-; 1,8,9-trihydroxy-3-methoxy-benzofuro[3,2-c]chromen-6-one; HMS2043P19; LMPK12090046; D0F8QJ; BDBM50096619; Wedelolactone, analytical standard; I07-0266; 6H-Benzofuro[3,2-c][1]benzopyran-6-one,1,8,9-trihydroxy-3-methoxy-; 1,8,9-Trihydroxy-3-methoxy-6H-[1]benzofuro[3,2-c]chromen-6-one; 1,8,9-trihydroxy-3-methoxy-[1]benzoxolo[3,2-c]chromen-6-one; Wedelolactone; 7-Methoxy-5,11,12-trihydroxy-coumestan |
C16H10O7 |
314.246 |
c1(O[H])c([H])c(c(C(=O)Oc(c([H])c(OC([H])([H])[H])c([H])c2O[H])c23)c3o4)c4c([H])c1O[H] |
TCMBANKIN038148 |
beta-Cuparenone |
β-cuparenone |
C15H20O |
216.319 |
C([H])([H])([H])c1c([H])c([H])c([C@]2(C([H])([H])[H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])C(=O)C2([H])[H])c([H])c1[H] |
TCMBANKIN039868 |
isocurcumenol |
isocurcum enol; LS-64023; MolPort-039-338-608; ZINC15160861; 24063-71-6; Isocurcumenol |
C15H22O2 |
234.334 |
[C@@]1([H])(C(=C([H])[H])C2([H])[H])[C@@]3([C@@]([H])(C([H])([H])[H])C([H])([H])C1([H])[H])O[C@]2(O[H])\C(=C(\C([H])([H])[H])/C([H])([H])[H])\C3([H])[H] |
TCMBANKIN039991 |
alpha-cuparenone |
α-cuparenone |
C15H20O |
216.32 g/mol |
CC1=CC=C(C=C1)C2(CCC(=O)C2(C)C)C |
TCMBANKIN040187 |
trans-Widdrol alpha-epoxie |
|
C15H26O2 |
238.366 |
C1([H])([H])C([H])([H])[C@]2(C([H])([H])[H])[C@@]3([C@@]([H])(O3)C([H])([H])[C@@](C([H])([H])[H])(O[H])C([H])([H])C2([H])[H])C(C([H])([H])[H])(C([H])([H])[H])C1([H])[H] |
TCMBANKIN040838 |
beta-cuparenol |
β-cuparenol |
C15H22O |
218.33 g/mol |
CC1=CC=C(C=C1)C2(CC(CC2(C)C)O)C |
TCMBANKIN044816 |
gamma-cuparenol |
|
C15H22O |
218.33 g/mol |
CC1(CCCC1(C)C2=CC=C(C=C2)CO)C |
TCMBANKIN045107 |
beta-Isobiotol |
β-isobiotol |
C15H24O |
220.35 |
C1([H])([H])C([H])([H])C(=C([H])[H])[C@]2([H])C([H])([H])[C@@]13[C@]([H])(C2(C([H])([H])[H])C([H])([H])[H])C([H])([H])[C@](O[H])([H])[C@]3(C([H])([H])[H])[H] |
TCMBANKIN045207 |
cis-Widdrol alpha-epoxide |
cis-widdrol α-epoxide; cis-widdrol alpha-epoxide |
C15H26O2 |
238.366 |
C1([H])([H])C([H])([H])[C@]2(C([H])([H])[H])[C@]3([C@]([H])(O3)C([H])([H])[C@@](C([H])([H])[H])(O[H])C([H])([H])C2([H])[H])C(C([H])([H])[H])(C([H])([H])[H])C1([H])[H] |
TCMBANKIN045427 |
alpha-cuprenene |
α-cuprenene |
C15H24 |
204.351 |
CC1=CC=C(CC1)C2(CCCC2(C)C)C |
TCMBANKIN047594 |
alpha-biotol |
α-biotol |
C15H24O |
220.35 g/mol |
CC1CC(C2C13CC=C(C(C3)C2(C)C)C)O |
TCMBANKIN047964 |
trans-Widdrol α-epoxide |
|
|
|
|
TCMBANKIN049185 |
dehydro-alpha-curcumene |
4999-58-0; AC1NSUA4; 1-methyl-4-(6-methylhepta-1,5-dien-2-yl)benzene; Bisabola-1,3,5,7(14),10-pentaene; dehydro-α-curcumene; YAZBKDRDYPAXAO-UHFFFAOYSA-N |
C15H20 |
200.32 g/mol |
CC1=CC=C(C=C1)C(=C)CCC=C(C)C |
TCMBANKIN049942 |
beta-Biotol |
β-biotol |
C15H24O |
220.35 |
[C@]1([H])(O[H])[C@]2([H])[C@@]3(C([H])([H])[C@]([H])(C(=C([H])[H])C([H])([H])C3([H])[H])C2(C([H])([H])[H])C([H])([H])[H])[C@]([H])(C([H])([H])[H])C1([H])[H] |
TCMBANKIN058224 |
Cupressuflavone |
8-[5,7-dihydroxy-2-(4-hydroxyphenyl)-4-oxo-8-chromenyl]-5,7-dihydroxy-2-(4-hydroxyphenyl)-4-chromenone; cupressuflavone ; 3952-18-9; 8-[5,7-dihydroxy-2-(4-hydroxyphenyl)-4-oxochromen-8-yl]-5,7-dihydroxy-2-(4-hydroxyphenyl)chromen-4-one; 8-[5,7-dihydroxy-2-(4-hydroxyphenyl)-4-keto-chromen-8-yl]-5,7-dihydroxy-2-(4-hydroxyphenyl)chromone; ST5331567; Cupressiflavone; C10034; 8-[5,7-dihydroxy-2-(4-hydroxyphenyl)-4-oxo-chromen-8-yl]-5,7-dihydroxy-2-(4-hydroxyphenyl)chromen-4-one; 8,8''-Biapigenin |
C30H18O10 |
538.46 |
C1=CC(=CC=C1C2=CC(=O)C3=C(O2)C(=C(C=C3O)O)C4=C(C=C(C5=C4OC(=CC5=O)C6=CC=C(C=C6)O)O)O)O |
TCMBANKIN059652 |
gamma-cuparenol |
|
C15H22O |
218.33 g/mol |
CC1(CCCC1(C)C2=CC=C(C=C2)CO)C |
TCMBANKIN059654 |
6892-80-4 |
|
C15H26O |
222.37 g/mol |
CC1(CCCC2(C1=CCC(CC2)(C)O)C)C |
TCMBANKIN059910 |
alpha-Cuparenol |
|
C15H22O |
218.33 |
CC1=CC=C(C=C1)C2(CCC(C2(C)C)O)C |
TCMBANKIN059972 |
gamma-cuprenene;γ-cuprenene |
|
C15H24 |
|
CC1=CCC(=CC1)C2(CCCC2(C)C)C |
TCMBANKIN059999 |
beta-Chamigrene |
|
C15H24 |
204.35 g/mol |
CC1=CCC2(CC1)C(=C)CCCC2(C)C |
TCMBANKIN060001 |
thujopsene |
|
C15H24 |
204.35 g/mol |
CC1=CCC2(CCCC(C23C1C3)(C)C)C |
TCMBANKIN060467 |
(6Z,10S)-3-isopropylidene-6,10-dimethyl-cyclodec-6-ene-1,4-quinone |
|
C15H22O2 |
234.33 |
CC1CCC=C(CC(=O)C(=C(C)C)CC1=O)C |
TCMBANKIN061333 |
Izoteolin |
Isoteolin; ST057702; 4H-Dibenzo(de,g)quinolinediol, 5,6,6a,7-tetrahydro-2,9(or 2,10)-dimethoxy-6-methyl-, (S)-; 95508-61-5; TNP00331; C09541; NCGC00142559-01; Isoboldine; Isoteoline; 6aalpha-Aporphine-1,9-diol, 2,10-dimethoxy-; NCGC00017381-01; isoboldine |
C19H21NO4 |
327.4 g/mol |
CN1CCC2=CC(=C(C3=C2C1CC4=CC(=C(C=C43)OC)O)O)OC |
TCMBANKIN061453 |
31098-60-9 |
mecambridine;(-)-mecambridine;27341-28-2; 6H-Benzo(g)-1,3-benzodioxolo(5,6-a)quinolizine-12-methanol, 5,8,13,13a-tetrahydro-10,11,14-trimethoxy-, (S)- |
C22H25NO6 |
399.44 |
COC1=C(C(=C2CC3C4=C(C5=C(C=C4CCN3CC2=C1)OCO5)OC)CO)OC |